EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSNGAG00000019565
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSNGAG00000003295
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSNGAG00000023475
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSNGAG00000014399
Gene Symbol: PSMA2
3 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSNGAG00000012537
Gene Symbol: PSMA3
2 Cross references
179 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSNGAG00000017002
Gene Symbol: PSMA4
3 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSNGAG00000012089
Gene Symbol: PSMA5
3 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSNGAG00000010628
Gene Symbol: PSMA6
3 Cross references
277 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSNGAG00000017073
Gene Symbol: PSMA7
3 Cross references
151 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSNGAG00000015507
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSNGAG00000011490
Gene Symbol: PSMB1
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSNGAG00000018966
Gene Symbol: PSMB10
3 Cross references
171 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).